Back to
What is the blood clotting disorder the AstraZeneca vaccine has been linked to?
The European Medicines Agency has concluded that there is a possible link between AstraZeneca’s COVID-19 vaccine and very rare blood clots. But what are these clots and how great is the risk?
8 April 2021 – by Linda Geddes
Read more
Back to
Gavi COVAX AMC
The Gavi COVAX AMC is the innovative financing instrument that will support the participation of 92 low- and middle-income economies in the COVAX Facility – enabling access to donor-funded doses of safe and effective COVID-19 vaccines.
Learn more
Back to
About our Alliance
As part of its mission to save lives, reduce poverty and protect the world against the threat of epidemics, Gavi has helped vaccinate more than 822 million children in the world’s poorest countries, preventing more than 14 million future deaths.
Who we are
Back to
Annual Progress Report 2019
The successes of 2019 are a testament to the power of the Vaccine Alliance – from our core partners to the dedicated, passionate people in countries and communities upon whose hard work and expertise we rely every day to protect the next generation.
Annual Progress Report 2019
Back to
Gavi's core focus and a new five-year strategy
In June 2019, the Gavi Board approved a new five-year strategy (‘Gavi 5.0’) with a vision to ‘leave no-one behind with immunisation’ and a mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines
Learn more
